1. Anti‐viral therapy can be delayed or avoided in a significant proportion of HBeAg‐negative Caucasian patients in the Grey Zone. Issue 10 (25th March 2018) Authors: Bonacci, M.; Lens, S.; Mariño, Z.; Londoño, M.‐C.; Rodríguez‐Tajes, S.; Mas, A.; García‐López, M.; Pérez‐del‐Pulgar, S.; Sánchez‐Tapias, J. M.; Forns, X. Journal: Alimentary pharmacology & therapeutics Issue: Volume 47:Issue 10(2018) Page Start: 1397 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗